Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: Preclinical evidence of immunogenicity and protection-Reference-Cited by-同舟云学术

Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: Preclinical evidence of immunogenicity and protection

Published:2007-08 Issue:33 Volume:25 Page:6167-6175
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Xu De Qi,Cisar John O.,Osorio Manuel,Wai Tint T.,Kopecko Dennis J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference45 articles.

1. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies;Kotloff;Bull World Health Organ,1999

2. Inoculum size in shigellosis and implications for expected mode of transmission;DuPont;J Infect Dis,1989

3. Bacillary dysentery: mechanisms and treatment;Levine;Med Clin N Am,1982

4. Shigellosis;Keusch,2005

5. The bacterial weaponry: lessons from Shigella;Sansonetti;Ann NY Acad Sci,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bactofection, Bacterial-Mediated Vaccination, and Cancer Therapy: Current Applications and Future Perspectives;Vaccines;2024-08-27

2. Oral Shigella Vaccines;Mucosal Vaccines;2020

3. Heterologous expression of Shigella dysenteriae serotype 1 O-antigen analog in Escherichia coli K-12 W3110 by transferring a minimum number of genes involved in O-polysaccharide biosynthesis;Biotechnology Letters;2018-06-21

4. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection;Vaccine;2018-02

5. Bacterial Glycoengineering as a Biosynthetic Route to Customized Glycomolecules;Advances in Glycobiotechnology;2018